PMA device
RefluxStop® Device and RefluxStop® Deployment Tool
Implantica CE Reflux , Ltd. · Implant, Anti-Gastroesophageal Reflux (LEI, Class III) · First FDA decision Aug 20, 2026, newest Aug 20, 2026Acid reflux (GERD)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
4
Naming "RefluxStop"
MAUDE reports
0
Brand "RefluxStop", since 2015
PubMed studies
40
Mentioning "RefluxStop"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P250018 · Decided Aug 20, 2026 · 423 days after receipt
Device type: IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX (LEI) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "RefluxStop", any status and sponsor, newest update first.
- A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital PracticeNot yet recruiting
Implantica CE Reflux Ltd.Not on our public-company list
NCT07004439 · 500 participants (planned) · Start Sep 15, 2025 · Primary completion Aug 1, 2029
Device: RefluxStop™ implantation · For: Gastroesophageal Reflux Disease
Sites: Friedrichshafen, Germany; Getafe, Spain; Alcázar de San Juan, Spain · 5 sites in all
- A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERDPivotal-lookingNot yet recruiting
Implantica CE Reflux Ltd.Not on our public-company list
NCT07004400 · 200 participants (planned) · Start Aug 1, 2025 · Primary completion Dec 1, 2026
Device: RefluxStop™ implantation · For: GERD (Gastroesophageal Reflux Disease)
Sites: Vienna, Austria; Frankfurt, Germany; Friedrichshafen, Germany · 4 sites in all
Implantica CE Reflux Ltd.Not on our public-company list
NCT05870163 · 2,500 participants (planned) · Start Feb 20, 2023 · Primary completion Dec 1, 2025
Device: RefluxStop implantation · For: Gastroesophageal Reflux Disease (GERD)
Sites: Friedrichshafen, Germany; Bari, Italy; Naples, Italy · 6 sites in all
- Evaluation of Safety and Effectiveness of the RefluxStop Device in the Management of GERDStatus unknown
Implantica CE Reflux Ltd.Not on our public-company list
NCT02759094 · 50 participants · Start Dec 2016 · Primary completion Mar 2018
Device: Treatment with RefluxStop · For: GERD
Sites: Budapest, Hungary; Debrecen, Hungary; Székesfehérvár, Hungary · 4 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "RefluxStop", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LEI
2,179 reports: 98 malfunction, 2,079 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "RefluxStop"[tiab]. The summary above synthesizes these.
- Budget Impact of RefluxStopࡊ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom.
Harper S, Grodzicki L, Mealing S, et al. · J Health Econ Outcomes Res · 2024
- Laparoscopic Large Hiatal Hernia Repair With RefluxStop: Outcomes of Six Months Follow-up in Thirty Patients.
Fringeli Y, Linas I, Kessler U, et al. · Surg Laparosc Endosc Percutan Tech · 2024
- Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease.
Harper S, Grodzicki L, Mealing S, et al. · J Med Econ · 2023
- A cost-effectiveness analysis of RefluxStop against relevant therapeutic alternatives for chronic gastroesophageal reflux disease in Sweden.
Harper S, Kartha M, Mealing S, et al. · Expert Rev Pharmacoecon Outcomes Res · 2024
- Cost-effectiveness of RefluxStop for gastroesophageal reflux disease: analysis from an Italian healthcare perspective.
Harper S, Kartha M, Mealing S, et al. · BMC Gastroenterol · 2026
- Short-term results of laparoscopic anti-reflux surgery with the RefluxStop device in patients with gastro-esophageal reflux disease and ineffective esophageal motility.
Fringeli Y, Linas I, Kessler U, et al. · Langenbecks Arch Surg · 2024
- Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
Harper S, Kartha M, Mealing S, et al. · J Med Econ · 2024
- The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System.
Harper S, Kartha M, Mealing S, et al. · Pharmacoecon Open · 2024
- Experience With an Innovative Surgical Treatment Option for Gastroesophageal Reflux Disease: Results of 28 Patients in a Retrospective Analysis.
Elshafei M · J Laparoendosc Adv Surg Tech A · 2025
- Five-year clinical outcomes of RefluxStop surgery in the treatment of acid reflux: a prospective multicenter trial of safety and effectiveness.
Harsányi L, Kincses Z, Veselinovik M, et al. · Surg Endosc · 2025Multicenter Study, Clinical Trial
- Treating acid reflux without compressing the food passageway: 4-year safety and clinical outcomes with the RefluxStop device in a prospective multicenter study.
Harsányi L, Kincses Z, Zehetner J, et al. · Surg Endosc · 2024Multicenter Study, Clinical Trial
- RefluxStopࡊ Therapy - a New Minimally Invasive Technology in Anti-reflux Surgery.
Stephan D, Borbely Y, Schoppmann SF · Surg Technol Int · 2022
Other devices of this type
Also filed under product code LEI.
- LINX Reflux Management SystemTorax Medical · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.